VERTUI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 100
NA - Nord America 70
AS - Asia 35
Totale 205
Nazione #
US - Stati Uniti d'America 70
IT - Italia 51
CN - Cina 30
IE - Irlanda 27
AT - Austria 9
FI - Finlandia 6
DE - Germania 3
CZ - Repubblica Ceca 2
IN - India 2
SG - Singapore 2
HK - Hong Kong 1
NL - Olanda 1
SE - Svezia 1
Totale 205
Città #
Dublin 27
Chandler 20
Milan 18
Shanghai 10
Pavia 9
Vienna 8
Helsinki 6
Ashburn 5
Boardman 3
Brescia 3
Laives 3
Los Angeles 3
Florence 2
Lawrence 2
Mariglianella 2
Medford 2
Moncalieri 2
New York 2
Piscataway 2
Princeton 2
Pune 2
Rho 2
Turin 2
Verona 2
West Jordan 2
Borås 1
Brno 1
Chicago 1
Den Haag 1
Fuzhou 1
Genoa 1
Hwang Chow 1
Mulazzano 1
Nanchang 1
Olomouc 1
Sacramento 1
Seattle 1
Shenyang 1
Zhengzhou 1
Totale 155
Nome #
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 52
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 41
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 40
Respiratory failure due to concomitant interstitial lung disease and diaphragmatic involvement in a patient with anti-MDA5 dermatomyositis: a case report 28
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 23
Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis 20
Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients 10
Totale 214
Categoria #
all - tutte 1.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 2 0 2 6
2022/202391 5 13 3 7 6 7 0 8 35 1 4 2
2023/2024111 3 8 0 4 31 7 4 2 5 28 7 12
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 214